Rare disease partnership champions market access in South America
Pharmaceutical Technology
FEBRUARY 28, 2023
On 27 February, HRA Pharma Rare diseases (HRA RD) announced a partnership with Celnova Pharma to cement its place in the South American market and increase access to needed rare disease treatments. HRA RD has a portfolio of three marketed drugs that treat the rare diseases Cushing’s Syndrome and adrenocortical Carcinoma. billion deal.
130 
Let's personalize your content